Home
MYGN
MYGN News

Latest Myriad Genetics Inc. (MYGN) News on July 26, 2024

Argus Research

3 days ago

MYGN: What does Argus have to say about MYGN?

INCY or MYGN: Which Is the Better Value Stock Right Now?

Zacks

8 days ago

INCY or MYGN: Which Is the Better Value Stock Right Now?

What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk

GlobeNewswire

9 days ago

What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk

Argus Research

10 days ago

MYGN: Raising target price to $22.00

Myriad Genetics (MYGN) Expands in MRD Testing With New Collab

Zacks

11 days ago

Myriad Genetics (MYGN) Expands in MRD Testing With New Collab

MT Newswires

15 days ago

Myriad Genetics, Personalis to Cross-License IP on Minimal Residual Disease Tests

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

GlobeNewswire

15 days ago

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

Myriad Genetics (MYGN) Advances in MRD Space With New Patent

Zacks

16 days ago

Myriad Genetics (MYGN) Advances in MRD Space With New Patent

Argus Research

17 days ago

MYGN: What does Argus have to say about MYGN?

MT Newswires

17 days ago

Myriad Genetics Receives New US Patent for Molecular Residual Disease Technology

Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

GlobeNewswire

17 days ago

Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

Morningstar Research

23 days ago

Analyst Report: Myriad Genetics, Inc.

Argus Research

24 days ago

MYGN: What does Argus have to say about MYGN?

Myriad Genetics Earns 2024 Great Place To Work® Certification™

GlobeNewswire

24 days ago

Myriad Genetics Earns 2024 Great Place To Work® Certification™

MT Newswires

a month ago

Scotiabank Initiates Myriad Genetics at Sector Outperform

Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election

GlobeNewswire

a month ago

Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election

An Intrinsic Calculation For Myriad Genetics, Inc. (NASDAQ:MYGN) Suggests It's 30% Undervalued

Simply Wall St.

a month ago

An Intrinsic Calculation For Myriad Genetics, Inc. (NASDAQ:MYGN) Suggests It's 30% Undervalued

Myriad Genetics (MYGN) and GSK Unite to Boost HRD Testing

Zacks

a month ago

Myriad Genetics (MYGN) and GSK Unite to Boost HRD Testing

Myriad Genetics (MYGN) Banks on Innovation Amid Macro Woes

Zacks

a month ago

Myriad Genetics (MYGN) Banks on Innovation Amid Macro Woes

MT Newswires

a month ago

Myriad Genetics, GSK Partner to Expand Access to HRD Diagnostic Testing

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

GlobeNewswire

a month ago

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

Myriad (MYGN) Down 5.2% Since Last Earnings Report: Can It Rebound?

Zacks

2 months ago

Myriad (MYGN) Down 5.2% Since Last Earnings Report: Can It Rebound?

Insider Sale: Director Daniel Spiegelman Sells Shares of Myriad Genetics Inc (MYGN)

GuruFocus.com

2 months ago

Insider Sale: Director Daniel Spiegelman Sells Shares of Myriad Genetics Inc (MYGN)

Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen

GlobeNewswire

2 months ago

Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

GlobeNewswire

2 months ago

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

QIAGEN (QGEN) Develops Test for Research and CDx Application

Zacks

2 months ago

QIAGEN (QGEN) Develops Test for Research and CDx Application

MT Newswires

2 months ago

Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications

GlobeNewswire

2 months ago

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications

Morningstar Research

2 months ago

Analyst Report: Myriad Genetics, Inc.

Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting

GlobeNewswire

2 months ago

Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting

New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer

GlobeNewswire

2 months ago

New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 05/16/2024

Insider Sale: President and CEO Paul Diaz Sells 227,844 Shares of Myriad Genetics Inc (MYGN)

GuruFocus.com

2 months ago

Insider Sale: President and CEO Paul Diaz Sells 227,844 Shares of Myriad Genetics Inc (MYGN)

Insider Sale: Director Lee Newcomer Sells 6,200 Shares of Myriad Genetics Inc (MYGN)

GuruFocus.com

2 months ago

Insider Sale: Director Lee Newcomer Sells 6,200 Shares of Myriad Genetics Inc (MYGN)

MT Newswires

2 months ago

Piper Sandler Adjusts Price Target on Myriad Genetics to $28 From $23, Maintains Neutral Rating

Analysts Have Made A Financial Statement On Myriad Genetics, Inc.'s (NASDAQ:MYGN) First-Quarter Report

Simply Wall St.

3 months ago

Analysts Have Made A Financial Statement On Myriad Genetics, Inc.'s (NASDAQ:MYGN) First-Quarter Report

Morningstar Research

3 months ago

Analyst Report: Myriad Genetics, Inc.

Myriad Genetics First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

3 months ago

Myriad Genetics First Quarter 2024 Earnings: Beats Expectations

Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2024 Earnings Call Transcript

MT Newswires

3 months ago

Sector Update: Health Care Stocks Softer Late Afternoon

Morningstar Research

3 months ago

Analyst Report: Myriad Genetics, Inc.

MT Newswires

3 months ago

Myriad Genetics Shares Rise After Reporting Narrower Q1 Adjusted Loss, Higher Revenue

Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1

Zacks

3 months ago

Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1

GuruFocus.com

3 months ago

Myriad Genetics Inc (MYGN) Q1 2024 Earnings Call Transcript Highlights: Strong Start with ...

Myriad (MYGN) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks

3 months ago

Myriad (MYGN) Reports Q1 Earnings: What Key Metrics Have to Say

Myriad Genetics Reports Q1 2024 Earnings: Revenue Growth Surpasses Estimates Amidst Challenges

GuruFocus.com

3 months ago

Myriad Genetics Reports Q1 2024 Earnings: Revenue Growth Surpasses Estimates Amidst Challenges

Myriad Genetics (MYGN) Reports Q1 Loss, Tops Revenue Estimates

Zacks

3 months ago

Myriad Genetics (MYGN) Reports Q1 Loss, Tops Revenue Estimates

Associated Press Finance

3 months ago

Myriad: Q1 Earnings Snapshot

Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA

GlobeNewswire

3 months ago

Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA

Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business

GlobeNewswire

3 months ago

Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business

Myriad Genetics (NASDAQ:MYGN) shareholders have endured a 26% loss from investing in the stock five years ago

Simply Wall St.

3 months ago

Myriad Genetics (NASDAQ:MYGN) shareholders have endured a 26% loss from investing in the stock five years ago

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

GlobeNewswire

3 months ago

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know

Zacks

3 months ago

Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know

Argus Research

3 months ago

MYGN: What does Argus have to say about MYGN?

Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor

GlobeNewswire

3 months ago

Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor

New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen

GlobeNewswire

3 months ago

New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen

Myriad Genetics (MYGN) Announces Favorable Research Results

Zacks

3 months ago

Myriad Genetics (MYGN) Announces Favorable Research Results

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Zacks

4 months ago

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

GlobeNewswire

4 months ago

Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?

Zacks

4 months ago

Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?

Why Is Myriad (MYGN) Down 1% Since Last Earnings Report?

Zacks

4 months ago

Why Is Myriad (MYGN) Down 1% Since Last Earnings Report?

Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay

Zacks

4 months ago

Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay

Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

GlobeNewswire

4 months ago

Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device

GlobeNewswire

4 months ago

Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device

Myriad Genetics (MYGN) to Evaluate MRD Testing With New Pact

Zacks

5 months ago

Myriad Genetics (MYGN) to Evaluate MRD Testing With New Pact

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

5 months ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Myriad Genetics Full Year 2023 Earnings: EPS Misses Expectations

Simply Wall St.

5 months ago

Myriad Genetics Full Year 2023 Earnings: EPS Misses Expectations

Morningstar Research

5 months ago

Analyst Report: Myriad Genetics, Inc.

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Myriad Genetics Inc Earnings Call

Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript

Myriad Genetics (MYGN) Q4 Earnings Top Estimate, Margins Down

Zacks

5 months ago

Myriad Genetics (MYGN) Q4 Earnings Top Estimate, Margins Down

Myriad (MYGN) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

5 months ago

Myriad (MYGN) Reports Q4 Earnings: What Key Metrics Have to Say

Myriad Genetics (MYGN) Tops Q4 Earnings and Revenue Estimates

Zacks

5 months ago

Myriad Genetics (MYGN) Tops Q4 Earnings and Revenue Estimates

Myriad Genetics Inc (MYGN) Reports 11% Revenue Growth in Q4 and Full-Year 2023

GuruFocus.com

5 months ago

Myriad Genetics Inc (MYGN) Reports 11% Revenue Growth in Q4 and Full-Year 2023

Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance

GlobeNewswire

5 months ago

Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance

Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3

GlobeNewswire

5 months ago

Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3

Wall Street's Insights Into Key Metrics Ahead of Myriad (MYGN) Q4 Earnings

Zacks

5 months ago

Wall Street's Insights Into Key Metrics Ahead of Myriad (MYGN) Q4 Earnings

Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

GlobeNewswire

5 months ago

Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Larry Robbins' Glenview Capital Management Bolsters Stake in Myriad Genetics Inc

GuruFocus.com

5 months ago

Larry Robbins' Glenview Capital Management Bolsters Stake in Myriad Genetics Inc

Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health

GlobeNewswire

5 months ago

Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health

Spire Inc. (NYSE:SR) Q1 2024 Earnings Call Transcript

Insider Monkey

6 months ago

Spire Inc. (NYSE:SR) Q1 2024 Earnings Call Transcript

Modine (MOD) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

6 months ago

Modine (MOD) is on the Move, Here's Why the Trend Could be Sustainable

Growth Investors: Industry Analysts Just Upgraded Their Spire Inc. (NYSE:SR) Revenue Forecasts By 3.9%

Simply Wall St.

6 months ago

Growth Investors: Industry Analysts Just Upgraded Their Spire Inc. (NYSE:SR) Revenue Forecasts By 3.9%

Thomson Reuters StreetEvents

6 months ago

Q1 2024 Spire Inc Earnings Call

Business Wire

6 months ago

Materion Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results on February 15

Spire Inc (SR) Reports Mixed Q1 FY24 Results Amid Market Normalization

GuruFocus.com

6 months ago

Spire Inc (SR) Reports Mixed Q1 FY24 Results Amid Market Normalization

Spire (SR) Q1 Earnings Surpass Estimates, Sales Fall Y/Y

Zacks

6 months ago

Spire (SR) Q1 Earnings Surpass Estimates, Sales Fall Y/Y

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

GlobeNewswire

6 months ago

Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics

Business Wire

6 months ago

Materion Corporation Declares Quarterly Cash Dividend

New Strong Sell Stocks for January 31st

Zacks

6 months ago

New Strong Sell Stocks for January 31st

Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology

GlobeNewswire

6 months ago

Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology

Oil market in for uncomfortable few weeks after drone strike

Yahoo Finance Video

6 months ago

Oil market in for uncomfortable few weeks after drone strike

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

CNW Group

6 months ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Barrons.com

6 months ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Blackstone Inc. (NYSE:BX) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Blackstone Inc. (NYSE:BX) Q4 2023 Earnings Call Transcript

AB: Climate Change May Increase the Risk of Modern Slavery

ACCESSWIRE

6 months ago

AB: Climate Change May Increase the Risk of Modern Slavery

Quest Diagnostics (DGX) Advances in Cancer Research With New Deal

Zacks

6 months ago

Quest Diagnostics (DGX) Advances in Cancer Research With New Deal

Got $500? 2 Real Estate Dividend Stocks to Buy and Hold Forever

Motley Fool

6 months ago

Got $500? 2 Real Estate Dividend Stocks to Buy and Hold Forever

CNX Resources Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

6 months ago

CNX Resources Full Year 2023 Earnings: Beats Expectations

Best Value Stocks to Buy for January 26th

Zacks

6 months ago

Best Value Stocks to Buy for January 26th

Share on Social Networks: